Evidence map›Paper›PMID 24227908›Full record

ReviewMediators of inflammation2013

Topical nonsteroidal anti-inflammatory drugs for macular edema.

Andrea Russo, Ciro Costagliola, Luisa Delcassi, Francesco Parmeggiani, Mario R Romano, Roberto Dell'Omo, Francesco Semeraro

Registry-linked trialOpen access · goldAbstract readReview
In one paragraph

Review in Mediators of inflammation, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04940338 (The Effect of Topical Corticosteroids and Topical NSAIDs Perioperatively on IL6 Levels in Aqueous Humor and on Incidence of PCME in Patients With NPDR), which is not on this map. Cited by 30 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 1 pooled it
5.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04940338 phase4completednot on this mapstarted 2021, after this paper: background citation

The Effect of Topical Corticosteroids and Topical NSAIDs Perioperatively on IL6 Levels in Aqueous Humor and on Incidence of PCME in Patients With NPDR

TypeinterventionalSponsorKlinički Bolnički Centar ZagrebRan2021 to 2022Enrolled90ConditionsCystoid Macular Edema Following Cataract SurgeryArmsBromfenac Ophthalmic 0.09% Ophthalmic Solution, Dexamethasone Ophthalmic, Placebo, Phacoemulsification surgery (PHACO)
3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 1 synthesis or guideline pooled it, 59 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Intravitreal Injections for Macular Edema in Silicone Oil Filled Eyes.Clinical ophthalmology (Auckland, N.Z.) · 2024
    Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Andrea RussoEye Clinic, Department of Neurological and Vision Sciences, University of Brescia, Piazzale Spedale Civili 1, 25123 Brescia, Italy.
Ciro Costagliola
Luisa Delcassi
Francesco Parmeggiani
Mario R Romano
Roberto Dell'Omo
Francesco Semeraro
University of Brescia · ITUniversity of Molise · ITFondazione Humanitas per la Ricerca · ITUniversity of Ferrara · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nonsteroidal anti-inflammatory drugs (NSAIDs) are nowadays widely used in ophthalmology to reduce eye inflammation, pain, and cystoid macular edema associated with cataract surgery. Recently, new topical NSAIDs have been approved for topical ophthalmic use, allowing for greater drug penetration into the vitreous. Hence, new therapeutic effects can be achieved, such as reduction of exudation secondary to age-related macular degeneration or diabetic maculopathy. We provide an updated review on the clinical use of NSAIDs for retinal diseases, with a focus on the potential future applications.

Indexed as

Administration, TopicalAgingAnimalsAnti-Inflammatory Agents, Non-SteroidalCataract ExtractionComplement System ProteinsDiabetic RetinopathyDisease ProgressionHumansMacular DegenerationMacular EdemaProstaglandin-Endoperoxide SynthasesProstaglandinsRetinal DiseasesAnti-Inflammatory Agents, Non-SteroidalComplement System ProteinsProstaglandin-Endoperoxide SynthasesProstaglandins

Identifiers

PMID24227908
PMCPMC3818914
OpenAlexW2160958632

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.